Ebvallo is the First and Only Approved Therapy in Europe for Adults and Children with EBV+ PTLD Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell...
ATA3219 Demonstrates Complete CD19-Specific B-Cell Depletion Against Systemic Lupus Erythematosus and Multiple Sclerosis Patient Peripheral Blood...
First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug Administration If Approved, Tab-cel Would be First Approved Therapy in U.S...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.